Navigation Links
Sony Medical Division Teams with Wills Eye Institute to Bring "Expert" Panel of Ophthalmologists to AAO 2012 Convention
Date:11/9/2012

CHICAGO, Nov. 9, 2012 /PRNewswire/ -- Sony Electronics' Medical Systems Division is sponsoring the renowned Wills Eye Institute's "Meet the Experts" panel, November 10-11 at this year's American Academy of Ophthalmology (AAO) Annual Meeting at Chicago's McCormick Place.

The two-day series of presentations, open to all AAO attendees, brings together 12 Wills Eye ophthalmologists, who will each deliver 15-minute talks on topics related to their specialty. The sessions will be held at the Wills Eye booth, #2635.

"Ophthalmology is changing rapidly, with so much that physicians need to be aware of, even beyond their own specialty," said Jack Scully, Director of Media Technology Services, Wills Eye Institute. "From the newest procedures to the latest developments in technology to patient relations, ophthalmologists need a diverse skill set and a broad level of knowledge about many topics. That's what this series is intended to provide, allowing attendees to walk away with valuable information they can put to use in their everyday practice."

Sony's sponsorship of these sessions continues its collaborations with Wills Eye Institute. The hospital is using a combination of Sony's HVO-1000MD recorder and PMW-10MD HD camera to form a unique capture and recording system. These products are helping Wills Eye use state-of-the-art technology to complement its faculty's expertise, help train residents and enhance teaching and presentation techniques -- both in the operating room and for reviewing procedures afterward. This shared vision of technology and medicine between the two organizations made this event sponsorship a mutually beneficial opportunity. Sony is also providing its LCD display products for use during the two-day event.

"Wills Eye is known for the highest standards of ophthalmic practice and training standards," said Anne Bondulich, marketing manager at Sony Electronics' Medical Systems Division. "They understand the importance of techn
'/>"/>

SOURCE Sony Electronics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 XRpro ... for drug discovery and development services which features ... the pharmaceutical industry, announced financial results for the ... Timothy C.  Tyson, Chairman of XRpro Sciences commented, ... successfully transition from development stage to commercial stage ...
(Date:3/27/2015)... March 27, 2015 According to ... (Diagnostic Catheter (Conventional, Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, ... Indication (AF, VT, WPW) - Global Forecasts to 2019 ", ... to reach around ~$4.73 Billion by 2019 with a ... to 2019. Browse   90   ...
(Date:3/27/2015)... , March 27, 2015  RXi Pharmaceuticals ... MirImmune LLC, today announced that they have ... RXi,s novel and proprietary sd-rxRNA® technology for ... The collaboration has the potential to result ... cancer treatments that could be a significant ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... Calif., May 18, 2011 Bayer HealthCare Pharmaceuticals, ... ONXX ) today announced results from a Phase ... with locally advanced or metastatic breast cancer previously ... Nexavar was associated with statistically significant improvements in ...
... SEATTLE, May 18, 2011 Dendreon Corporation (Nasdaq: ... poster presentation detailing clinical trial plans for PROVENGE® (sipuleucel-T) and ... upcoming American Society for Clinical Oncology annual meeting in Chicago, ... on Monday, June 6, 2011, from 8:00 a.m. to 12:00 ...
Cached Medicine Technology:Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 2Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 3Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 4Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 5Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 6Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 7Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 8Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting 2Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting 3Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting 4
(Date:3/28/2015)... India Network visitor health insurance announced ... visitors who purchase the plan before arrival in the ... purchase the insurance program as soon as travel plans ... pre-existing medical conditions. Parents and grandparents traveling from India ... serious consequences to their health. Many visitors may not ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... injuries is a growing field in orthopaedic medicine. While ... labral tear to confirm the pain etiology, research presented ... ( AOSSM ) Specialty Day suggests that pain relief ... following arthroscopic hip surgery. , “Our study looked ...
(Date:3/28/2015)... March 28, 2015 Lately the ... regarding recent changes and proposals around the NCAA. In ... and former collegiate student-athletes across a spectrum of universities ... on common challenges. The special panel consists of athletes ... sports ranging from football, track and field, baseball, and ...
(Date:3/28/2015)... March 28, 2015 ARDX will sponsor the ... 12pm -3pm at the Chesapeake Conference Center in Chesapeake, Virginia. ... an empowering event for women in the Hampton Roads region. ... Stories of Women’s Lives. Women grow stronger through sharing ... other. This year the WWC™ theme is T-talk where ...
(Date:3/27/2015)... Wellness for Cancer–the first organization to ... the spa and wellness industry–has certified Hands On to ... or are living with cancer. Hands On , ... will be identified with a special Wellness for Cancer ... safe, therapeutic services for cancer patients. , Wellness for ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4
... Its Educational and Entertaining MusicMINNETONKA, Minn., May 6 ... activities for young children, today announced that its founder, ... The National Parenting Center for her new CD, "Dance ... "really impressed ... with its ability to entertain and ...
... SOUTH SAN FRANCISCO, Calif., May 6 Sunesis Pharmaceuticals, ... results for the first quarter ended March 31, 2009.Total ... million, with a net loss of $8.4 million, including ... 2009, cash, cash equivalents and marketable securities totaled $4.3 ...
... China, May 6 /PRNewswire-Asia/ -- China Medicine ... "the Company"), a developer,and a leading distributor ... Chinese medicines (TCM), nutritional and dietary supplements, ... that it will conduct,a conference call at ...
... NeoStem, Inc. (NYSE Amex: NBS ), ... storage of adult stem cells for future medical need, ... cell technology of Vincent C. Giampapa, M.D., F.A.C.S. ... in February 2009.The newest adult stem cell collection center ...
... ENMD ), a clinical-stage pharmaceutical company developing ... today reported financial results for the three months ended ... ) , The Company reported a net loss ... ($0.04) per share, compared with a net loss of ...
... Md., May 6 Micromet, Inc. (Nasdaq: ... for the treatment of cancer, inflammation and autoimmune diseases, ... ended March 31, 2009.In the first quarter of 2009, ... continued progress in the clinic and in corporate development. ...
Cached Medicine News:Health News:Tessa, of Dancercise Kids, Wins the National Parenting Center's Seal of Approval for New Children's Music CD 2Health News:Sunesis Reports Financial Results for the First Quarter 2009 2Health News:Sunesis Reports Financial Results for the First Quarter 2009 3Health News:Sunesis Reports Financial Results for the First Quarter 2009 4Health News:Sunesis Reports Financial Results for the First Quarter 2009 5Health News:Sunesis Reports Financial Results for the First Quarter 2009 6Health News:Sunesis Reports Financial Results for the First Quarter 2009 7Health News:Sunesis Reports Financial Results for the First Quarter 2009 8Health News:Sunesis Reports Financial Results for the First Quarter 2009 9Health News:China Medicine Announces Conference Call to Discuss First Quarter 2009 Results 2Health News:NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey 2Health News:NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey 3Health News:EntreMed Reports First Quarter 2009 Financial Results 2Health News:EntreMed Reports First Quarter 2009 Financial Results 3Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 2Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 3Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 4Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 5Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 6Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 7Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 8Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 9
For the quantitative determination of calcium in serum. Endpoint Reaction Product measured at 570 nm Linearity: 20 mg/dl...
Alanine Aminotransferase (ALT) reagent is used for the quantitative determination of alanine aminotransferase (Glutamate pyruvate transaminase, SGPT) in human serum....
... Intended for the quantitative determination ... serum or plasma. Two vials, ... tablets must be purchased separately ... Kinetic reaction. Wavelength: 340 nm. ...
... quantitative determination of alanine aminotransferase ... Single vial, dry powder reagent. ... purchased separately for conformity to ... 340 nm. Linearity: 440 U/L ...
Medicine Products: